|
시장보고서
상품코드
2084650
합성 줄기세포 시장 : 유형별, 용도별, 최종사용자별, 지역별Synthetic Stem Cell Market, By Type, By Application, By End User, By Geography |
||||||
합성 줄기세포 시장 규모는 2026년에 112억 달러로 추정되고 있으며, 2033년까지 468억 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 22.7%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 112억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 22.70% | 2033년 시장 규모 예측 : | 468억 달러 |
합성 줄기세포 시장은 천연 줄기세포의 주요 기능을 모방한 인공적인 세포 유사 구조의 개발을 통해 재생의학에 크게 기여할 것으로 기대되고 있습니다. 합성 아날로그는 예를 들어 생물학적 활성, 분화, 자가 재생과 같은 측면에서 천연 줄기세포를 재현할 수 있는 한편, 윤리, 생산, 고유한 위험과 같이 천연 줄기세포 사용에 수반되는 문제를 피할 수 있습니다.
바이오소재, 나노테크놀러지, 세포공학 분야의 혁신적인 발전은 심혈관 질환, 신경퇴행성 질환, 정형외과 질환 및 종양 질환 치료에 있으며, 합성 줄기세포의 광범위한 응용을 촉진하는 원동력이 되고 있습니다. 이는 맞춤형 의료 분야에서 조직 재생, 약물전달 및 면역 조절에 대한 치료적 접근법으로 활용될 수 있으며, 확장성이 뛰어나고 표준화되어 있으며 비용 대비 효과가 뛰어난 치료법입니다.
시장 역학
전 세계 합성 줄기세포 시장은 만성질환 유병률의 증가, 고령 인구 확대, 그리고 기존 줄기세포 치료에 비해 더 안전하고 면역원성이 낮은 대안을 제공하는 재생의학에 대한 수요 증가에 힘입어 성장하고 있습니다. 나노테크놀러지, 바이오소재공학, 세포 재프로그래밍 등 각 분야의 발전으로 인해 합성 줄기세포의 치료적 유용성이 높아지면서, 심혈관 질환, 신경계 질환, 정형외과 질환의 치료에 대한 응용이 촉진되고 있습니다. 또한 재생의학 관련 조사에 대한 투자 증가와 정부의 지원 정책이 맞물려 시장 성장에 긍정적인 영향을 미치고 있습니다.
그러나 시장에는 높은 연구개발비 및 제조 비용, 복잡한 규제 장벽, 안전성과 유효성에 관한 장기적인 임상 데이터 부족 등 몇 가지 제약 요인이 존재합니다. 생체적합성, 안정성, 그리고 규제 승인을 받기까지의 장기적인 기간 등은 상용화를 저해할 수 있는 과제 중 일부입니다. 그럼에도 불구하고 맞춤형 의료, 신약 개발 및 병용 요법 분야의 적용 범위가 확대됨에 따라 이 시장의 전망은 여전히 밝습니다. 의료비 증가에 더해, 다양한 질환에 대해 확장성이 뛰어나면서도 합리적인 가격의 치료 솔루션을 제공할 수 있는 가능성도 유망한 성장 기회를 가져다줄 것으로 전망됩니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 합성 줄기세포 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- '세계의 합성 줄기세포 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 합성 줄기세포 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 합성 줄기세포 시장 : 유형별, 2021-2033년
제5장 세계의 합성 줄기세포 시장 : 용도별, 2021-2033년
제6장 세계의 합성 줄기세포 시장 : 최종사용자별, 2021-2033년
제7장 세계의 합성 줄기세포 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
KSA 26.07.14Synthetic Stem Cell Market is estimated to be valued at USD 11.2 Bn in 2026 and is expected to reach USD 46.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 22.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 11.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 22.70% | 2033 Value Projection: | USD 46.8 Bn |
The synthetic stem cells market is expected to greatly contribute to regenerative medicine, due to the development of artificial, cell-like structures that mimic key natural stem cell functions. Synthetic analogues can copy natural stem cells for example in terms of the biological activity, differentiation and self-renewal, without the problems associated with using natural stem cells, in terms of ethics, production and inherent risks.
Innovative advancements in biomaterials, nanotechnology, and cell engineering are the driving forces for the widespread application of synthetic stem cells for treating cardiovascular diseases, neurodegenerative disorders, orthopedic and oncological conditions. It can be utilized as a therapeutic approach to tissue repair, drug delivery and immunomodulation in personalized medicine and is a scalable, standardized, and cost-effective treatment.
Market Dynamics
The global synthetic stem cell market is driven by the growing prevalence of chronic disorders, expanding geriatric population and increasing demand for regenerative therapies offering safer and less immunogenic alternative over traditional stem cell therapy. Advancements in the fields of nanotechnology, biomaterials engineering, and cell reprogramming have increased the therapeutic utility of synthetic stem cells and is fueling their application in treating cardiovascular, neurological and orthopedic diseases. Additionally, increased investments in research related to regenerative medicine coupled with favorable government policies are further impacting the growth of the market positively.
However, a number of constraints are present in the market, such as high R&D and production costs, complex regulatory hurdles, and paucity of long-term clinical data on its safety and efficacy. Biocompatibility, stability, and long-term regulatory approval times are among the issues that may hinder commercialization. Nevertheless, the opportunities within this market remain promising due to wider applications in areas of personalized medicine, drug discovery and combination therapies. The growing health expenditures, along with a capacity to offer potentially scalable and affordable therapeutic solution to various diseases is also poised to offer favorable growth opportunities.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global synthetic stem cell market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include BlueRock Therapeutics, Evotec SE, Pluri Inc., Celularity Inc., StemBioSys Inc., LifeCell International Pvt. Ltd., REPROCELL Inc., Lonza Group AG, Thermo Fisher Scientific Inc., and Merck KGaA
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global synthetic stem cell market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global synthetic stem cell market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2021 - 2033)
- Cell-Mimicking Microparticles (CMMPs)
- Polymer-Based Synthetic Stem Cells
- Biomimetic Nanoparticle Stem Cells
- Hydrogel-Based Synthetic Stem Cells
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Cardiovascular Disorders
- Neurological Disorders
- Musculoskeletal Disorders
- Cancer Therapy
- Wound Healing and Tissue Regeneration
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Research Laboratories
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Specialty Clinics
- Contract Research Organizations (CROs)
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- BlueRock Therapeutics
- Evotec SE
- Pluri Inc.
- Celularity Inc.
- StemBioSys Inc.
- LifeCell International Pvt. Ltd.
- REPROCELL Inc.
- Lonza Group AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Synthetic Stem Cell Market, By Type
- Global Synthetic Stem Cell Market, By Application
- Global Synthetic Stem Cell Market, By End User
- Global Synthetic Stem Cell Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Synthetic Stem Cell Market, By Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cell-Mimicking Microparticles (CMMPs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Polymer-Based Synthetic Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biomimetic Nanoparticle Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hydrogel-Based Synthetic Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Synthetic Stem Cell Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cancer Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Wound Healing and Tissue Regeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Synthetic Stem Cell Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hospitals and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Synthetic Stem Cell Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- BlueRock Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evotec SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pluri Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Celularity Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- StemBioSys Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LifeCell International Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- REPROCELL Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
